Intelligent Fingerprinting: Fingerprint Drug Screen Test Works on the Living and Deceased
New research published in the Journal of Analytical Toxicology shows how fingerprint-based drug screening can not only screen for the presence, or absence, of four classes of drugs of abuse, but that the technology also works when used by UK coroners to detect drugs in the sweat of fingerprint samples gathered from deceased individuals.
The Intelligent Fingerprinting Drug Screening System enables the detection of four drug classes (amphetamines, cannabis, cocaine and opiates) from a single fingerprint sample in just ten minutes. Its use in coroner mortuaries demonstrates the value of the revolutionary system that’s also being used in drug rehabilitation centres, workplaces and schools. Studies are also underway for its use in airport screening and offender management applications within prisons and probation services.
View a video demonstrating fingerprint-based drug testing in action here.
“This new research highlights how our lateral flow drug screening cartridge can screen rapidly for drug use in individuals using a fingerprint sample with a sample collection time of only five seconds, and a total analysis time of ten minutes,” said David Russell, Emeritus Professor at the University of East Anglia, UK, a co-author of the research and Intelligent Fingerprinting’s Founder and Chief Scientific Officer. “Our study also showed how our technology is being used by coroners to assist in gaining early understanding of the possible cause of death, and to inform potential further post-mortem activities or quickly facilitate police investigations.
“We matched the coroners’ drug test results obtained using our fingerprint drug screen with a second sample tested in laboratory conditions, achieving excellent correlation in terms of accuracy,” he added. “We also compared our results with toxicological analysis of blood and urine samples, with a good correlation of results.”
“This important research demonstrates how there is sufficient sweat present in a subject’s fingerprint, regardless of whether the person is alive or dead, to enable our fingertip-based drug screening system to detect the presence of four major drugs of abuse at the same time,” added Intelligent Fingerprinting’s Dr Paul Yates.
Full press release https://www.intelligentfingerprinting.com/analytical-toxicology/
www.intelligentfingerprinting.com Twitter @iFingerprinting
For Intelligent Fingerprinting
+44 (0)7791 720460
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Enevate Secures Funding from LG Chem to Accelerate Fast Charge Li-Ion Battery Technology Development for Electric Vehicles23.10.2018 10:00 | Pressemelding
Enevate Corporation, an advanced lithium-ion (Li-ion) battery technology company, announced that LG Chem, a leading high volume battery manufacturer in South Korea, has participated in Enevate’s recent funding. This investment is a nod to the viability of Enevate’s technology which could enable Electric Vehicles (EVs) to charge in the same time as gas cars without compromise. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181023005147/en/ Enevate’s HD-Energy® Technology for EVs allows Li-ion batteries to be charged to 75 percent capacity in five minutes, while also providing higher energy densities than available for today’s current long-range EVs. They can also safely charge and discharge down to -40°C and capture more energy during regenerative braking, extending their range in cold climates. “The strategic investment from LG Chem indicates the significance of our technology because it could directly address consumer conce
STEMCELL Submits Drug Master File for mTeSR™1, the Most Widely Published Cell Culture Medium for Human Pluripotent Stem Cells23.10.2018 10:00 | Pressemelding
STEMCELL Technologies announced it has filed a Type II Drug Master File (DMF) to the Food and Drug Administration (FDA) for the Cellular Therapy Ancillary Material mTeSR™1 and has been issued DMF# 18339. mTeSR™1 is an Ancillary Material used in basic and translational research to maintain and expand human pluripotent stem cells (hPSCs) in the undifferentiated state. Used in over 1500 peer-reviewed publications, mTeSR™1 is the most widely published feeder-free cell culture medium, with established protocols for applications ranging from cell line derivation to terminal differentiation. With pre-screened raw materials that ensure batch-to-batch consistency, mTeSR™1 provides robust cultures with homogeneous, undifferentiated phenotypes. “Advancing our cGMP (Current Good Manufacturing Practices) Ancillary Material suite of products is a top priority for STEMCELL. This further demonstrates to our customers that we are a trusted partner for their bench to bedside translational journey,” says
Malta and Austria Are Home to the World’s Best Investment Migration Programs23.10.2018 09:00 | Pressemelding
The Malta Individual Investor Program is the world’s top citizenship-by-investment program and the Austria Private Residence Program is the world’s top residence-by-investment program, according to the Global Residence and Citizenship Programs 2018–2019 report, released today by global residence and citizenship advisory firm Henley & Partners. Dr. Christian H. Kälin, an international immigration and citizenship law expert and Group Chairman of Henley & Partners, says the annual report provides a systematic analysis and comprehensive benchmarking of the world’s most important programs. “It’s an invaluable tool for anyone interested in alternative residence or citizenship as well as for the professionals like private bankers and lawyers who advise them. It also provides governments with a detailed picture of the broader investment migration industry landscape and where they fit it.” Malta is followed in the citizenship program ranking by Cyprus in 2nd place, Austria in 3rd place, and Ant
Temenos Ramps up AI Efforts to Power its Digital Banking Platform23.10.2018 08:30 | Pressemelding
Temenos (SIX: TEMN), the banking software company, today announced during the Machine Learning Panel at Sibos that it is increasing the development of Artificial Intelligence capabilities throughout its digital banking platform. The Temenos AI initiative will enable banks to offer personalized services to customers, augment users’ decisions with data-driven machine intelligence, and maximise straight-through-processing (STP) rates for financial transactions at reduced cost with limited or no human intervention. As part of this global initiative, Temenos has just launched a Centre of Excellence for Artificial Intelligence as its innovation engine. The Temenos AI Centre of Excellence will foster a collaborative ecosystem with Temenos’ banking clients and partners to help identify and validate use cases where AI could have an immediate impact on customer experience, as well as operational excellence, and hence improve the bottom line. Temenos’ pioneering initiative will involve injecting
ECAC EDS CB C3 Approval for Smiths Detection Technology23.10.2018 08:00 | Pressemelding
Smiths Detection has gained ECAC EDS CB C3 approval for the innovative HI-SCAN 6040 CTiX checkpoint scanner. This eliminates the need to remove electronic devices and liquids from hand luggage (subject to local authority guidelines) to make the process more passenger friendly. The HI-SCAN 6040 CTiX delivers the highest levels of security demanded by the new regulations, whilst optimizing checkpoint performance through improved productivity, a better passenger experience and lower operational costs. Removing the need to take out electronic devices and liquids from hand luggage means handling fewer trays which can significantly increase checkpoint throughput and the impressive 0.2m/s belt speed and low false alarm rate also speed up the process. “As the only technology meeting EDS CB C3 (and potentially future C4) standards, Computed Tomography (CT) is undoubtedly the way forward for checkpoint security,” commented Matt Clark, VP Technology & Product Development, Smiths Detection. “With
VIB 9–month profit before tax rises 176% YoY to VND 1,720 billion, Retail revenue increases 92% YoY23.10.2018 07:48 | Pressemelding
Vietnam International Bank (UPCoM: VIB) announced its financial statements of the first 9 months 2018 with positive results. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181023005507/en/ A clerk at VIB (Photo: Business Wire) Profit before tax grows 176% VIB reported profit before tax of VND 1,720 billion, up 176% year-on-year (YoY), equal to 86% of its full year target. The revenue increased by 48% YoY, in which interest income and non-interest income up 50% and 37% respectively; the latter accounted for 16% of total revenue and continued upward trend. The cost-to-income ratio (CIR) significantly dropped from 57% in 2017 to 48%. Provision expense in 9 months was lower than YoY in the context that VIB no longer has bad debts in VAMC. The return on equity ratio (ROE) reached 19.4%. The total asset of the bank reached over VND 132,500 billion, up 8% year-to-date; lending and deposits reached VND 95,200 billion and VND 89,200